DCM
LKFT

Driehaus Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Driehaus Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,235
Closed -$309K – 428
2024
Q4 		$309K Hold
11,235
– – ﹤0.01% 373
2024
Q3 		$323K Hold
11,235
– – ﹤0.01% 356
2024
Q2 		$278K Hold
11,235
– – ﹤0.01% 345
2024
Q1 		$362K Hold
11,235
– – ﹤0.01% 358
2023
Q4 		$457K Hold
11,235
– – 0.01% 342
2023
Q3 		$388K Hold
11,235
– – 0.01% 358
2023
Q2 		$457K Hold
11,235
– – 0.01% 346
2023
Q1 		$434K Hold
11,235
– – 0.01% 341
2022
Q4 		$499K Sell
11,235
-317,353
-97% -$13.4M 0.01% 313
2022
Q3 		$14M Sell
328,588
-182,061
-36% -$9.33M 0.21% 145
2022
Q2 		$28.5M Buy
510,649
+33,034
+7% +$1.96M 0.46% 57
2022
Q1 		$29.6M Buy
+477,615
New +$29.2M 0.36% 90
2017
Q4 		– Sell
-5,988
Closed -$609K – 563
2017
Q3 		$609K Sell
5,988
-4,815
-45% -$421K 0.02% 368
2017
Q2 		$827K Sell
10,803
-125
-1% -$10.5K 0.03% 366
2017
Q1 		$942K Buy
+10,928
New +$787K 0.03% 368
2016
Q1 		– Sell
-26,890
Closed -$1.69M – 582
2015
Q4 		$1.69M Buy
+26,890
New +$1.37M 0.06% 323

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Driehaus Capital Management's LKFT Position: Q1 2025 in Review

Driehaus Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2025, closing a stake of 11,235 shares — an estimated $309K sold.

Driehaus Capital Management first reported a position in LKFT in Q4 2015 and held it in 16 quarters. The position peaked at $29.6M in Q1 2022. 83 funds tracked by Wall St. Rank hold LKFT as of Q1 2025.

  • Driehaus Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 11,235 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2025, an estimated $309K.
  • Driehaus Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and held it in 16 quarters.
  • Driehaus Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $29.6M in Q1 2022.
  • 83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2025.

Based on Driehaus Capital Management's 13F filing for Q1 2025, filed 15 May 2025.